2025 annual financial data
Lexeo Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -109,257,000 USD and net income was -99,961,000 USD.
Operating cash flow was -98,561,000 USD.
Get free Lexeo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -109,257,000 USD
- Net income
- -99,961,000 USD
- Operating cash flow
- -98,561,000 USD